Showing results (161-170 of 168) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Molecular Therapy. Methods & Clinical Development|November 11, 2021
Seven-year follow-up of durability and safety of AAV CNS gene therapy for a lysosomal storage disorder in a large animalSara Marcó, Virginia Haurigot, Maria Luisa Jaén, et al.Journal of Clinical Medicine|December 6, 2018
Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer PatientsFrancisco Hermida-Prado, Sofía T Menéndez, Pablo Albornoz-Afanasiev, et al.EMBO Molecular Medicine|July 11, 2018
FGF21 gene therapy as treatment for obesity and insulin resistanceVeronica Jimenez, Claudia Jambrina, Estefania Casana, et al.Head & Neck|August 16, 2019
Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primaryPaolo Boscolo-Rizzo, Lea Schroeder, Valeria Sacchetto, et al.European Journal of Neurology|December 17, 2024
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcomeGabriel Bsteh, Robert Hoepner, Jonathan A Gernert, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 3, 2024
Reversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapyVeronica Jimenez, Victor Sacristan, Claudia Jambrina, et al.Frontiers in Neurology|August 1, 2022
Absence of Susceptibility Vessel Sign in Patients With Malignancy-Related Acute Ischemic Stroke Treated With Mechanical ThrombectomyMorin Beyeler, Nebiyat F Belachew, Moritz Kielkopf, et al.Journal of the National Cancer Institute|January 30, 2016
HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 PatientsXavier Castellsagué, Laia Alemany, Miquel Quer, et al.Pageof 17